Real-time enrollment status for this brca1/2-associated hereditary breast and ovarian cancer syndrome clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 9:56 AM UTC
| NCT Number | NCT04494945 |
| Recruiting Status | Recruiting |
| Condition | BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome |
| Phase | NA |
| Target Enrollment | 27,500 participants |
| Active Locations | 2 sites in the US |
| Sponsor | OHSU Knight Cancer Institute |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of September 2, 2026: Clinical trial NCT04494945 is currently recruiting participants. This na study for brca1/2-associated hereditary breast and ovarian cancer syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by OHSU Knight Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04494945 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04494945 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.